Financhill
Sell
42

URI Quote, Financials, Valuation and Earnings

Last price:
$645.85
Seasonality move :
7.25%
Day range:
$612.87 - $632.85
52-week range:
$585.27 - $896.98
Dividend yield:
1.06%
P/E ratio:
16.32x
P/S ratio:
2.74x
P/B ratio:
4.79x
Volume:
559.8K
Avg. volume:
737.3K
1-year change:
-11.01%
Market cap:
$41.3B
Revenue:
$15.3B
EPS (TTM):
$38.72
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5B $9.7B $11.6B $14.3B $15.3B
Revenue Growth (YoY) -8.78% 13.9% 19.82% 23.11% 7.07%
 
Cost of Revenues $5.3B $5.9B $6.6B $8.5B $9.2B
Gross Profit $3.2B $3.9B $5B $5.8B $6.2B
Gross Profit Margin 37.32% 39.66% 42.91% 40.56% 40.08%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $979M $1.2B $1.4B $1.5B $1.6B
Other Inc / (Exp) -$9M -$12M $15M -$9M $11M
Operating Expenses $1.4B $1.6B $1.8B $2B $2.1B
Operating Income $1.8B $2.3B $3.2B $3.9B $4.1B
 
Net Interest Expenses $669M $424M $445M $635M $691M
EBT. Incl. Unusual Items $1.1B $1.8B $2.8B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $249M $460M $697M $787M $813M
Net Income to Company $890M $1.4B $2.1B $2.4B $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $890M $1.4B $2.1B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $12.24 $19.14 $29.77 $35.40 $38.82
Diluted EPS (Cont. Ops) $12.20 $19.04 $29.65 $35.28 $38.69
Weighted Average Basic Share $72.7M $72.4M $70.7M $68.5M $66.3M
Weighted Average Diluted Share $72.9M $72.8M $71M $68.7M $66.6M
 
EBITDA $3.8B $4.3B $5.5B $6.6B $7B
EBIT $1.8B $2.3B $3.2B $3.8B $4.1B
 
Revenue (Reported) $8.5B $9.7B $11.6B $14.3B $15.3B
Operating Income (Reported) $1.8B $2.3B $3.2B $3.9B $4.1B
Operating Income (Adjusted) $1.8B $2.3B $3.2B $3.8B $4.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.3B $2.8B $3.3B $3.7B $4.1B
Revenue Growth (YoY) -7.21% 21.81% 18.73% 13.11% 9.84%
 
Cost of Revenues $1.4B $1.6B $1.8B $2.2B $2.5B
Gross Profit $869M $1.2B $1.5B $1.6B $1.6B
Gross Profit Margin 38.13% 41.82% 45.15% 41.9% 40%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $258M $322M $378M $393M $436M
Other Inc / (Exp) -$4M -$9M $3M -$4M $2M
Operating Expenses $353M $415M $464M $495M $551M
Operating Income $516M $746M $1B $1.1B $1.1B
 
Net Interest Expenses $125M $93M $132M $161M $180M
EBT. Incl. Unusual Items $387M $644M $895M $902M $909M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $90M $163M $256M $223M $220M
Net Income to Company $297M $481M $639M $679M $689M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $297M $481M $639M $679M $689M
 
Basic EPS (Cont. Ops) $4.11 $6.63 $9.21 $10.03 $10.49
Diluted EPS (Cont. Ops) $4.09 $6.61 $9.15 $9.98 $10.44
Weighted Average Basic Share $72.2M $72.5M $69.4M $67.6M $65.6M
Weighted Average Diluted Share $72.7M $73.2M $69.9M $68M $66M
 
EBITDA $992M $1.3B $1.6B $1.8B $1.9B
EBIT $512M $737M $1B $1.1B $1.1B
 
Revenue (Reported) $2.3B $2.8B $3.3B $3.7B $4.1B
Operating Income (Reported) $516M $746M $1B $1.1B $1.1B
Operating Income (Adjusted) $512M $737M $1B $1.1B $1.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5B $9.7B $11.6B $14.3B $15.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.3B $5.9B $6.6B $8.5B $9.2B
Gross Profit $3.2B $3.9B $5B $5.8B $6.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $979M $1.2B $1.4B $1.5B $1.6B
Other Inc / (Exp) -$9M -$12M $15M -$9M $11M
Operating Expenses $1.4B $1.6B $1.8B $2B $2.1B
Operating Income $1.8B $2.3B $3.2B $3.9B $4.1B
 
Net Interest Expenses $669M $424M $445M $635M $691M
EBT. Incl. Unusual Items $1.1B $1.8B $2.8B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $249M $460M $697M $787M $813M
Net Income to Company $890M $1.4B $2.1B $2.4B $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $890M $1.4B $2.1B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $12.26 $19.12 $29.88 $35.43 $38.84
Diluted EPS (Cont. Ops) $12.22 $19.06 $29.76 $35.32 $38.72
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.8B $4.3B $5.5B $6.6B $7B
EBIT $1.8B $2.3B $3.2B $3.8B $4.1B
 
Revenue (Reported) $8.5B $9.7B $11.6B $14.3B $15.3B
Operating Income (Reported) $1.8B $2.3B $3.2B $3.9B $4.1B
Operating Income (Adjusted) $1.8B $2.3B $3.2B $3.8B $4.1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $9.7B $11.6B $14.3B $15.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.9B $6.6B $8.5B $9.2B --
Gross Profit $3.9B $5B $5.8B $6.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.4B $1.5B $1.6B --
Other Inc / (Exp) -$12M $15M -$9M $11M --
Operating Expenses $1.6B $1.8B $2B $2.1B --
Operating Income $2.3B $3.2B $3.9B $4.1B --
 
Net Interest Expenses $424M $445M $635M $691M --
EBT. Incl. Unusual Items $1.8B $2.8B $3.2B $3.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $460M $697M $787M $813M --
Net Income to Company $1.4B $2.1B $2.4B $2.6B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.4B $2.1B $2.4B $2.6B --
 
Basic EPS (Cont. Ops) $19.12 $29.88 $35.43 $38.84 --
Diluted EPS (Cont. Ops) $19.06 $29.76 $35.32 $38.72 --
Weighted Average Basic Share $289.7M $282.8M $273.9M $265.4M --
Weighted Average Diluted Share $291.3M $284M $274.9M $266.3M --
 
EBITDA $4.3B $5.5B $6.6B $7B --
EBIT $2.3B $3.2B $3.8B $4.1B --
 
Revenue (Reported) $9.7B $11.6B $14.3B $15.3B --
Operating Income (Reported) $2.3B $3.2B $3.9B $4.1B --
Operating Income (Adjusted) $2.3B $3.2B $3.8B $4.1B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $202M $144M $106M $363M $457M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.7B $2B $2.2B $2.4B
Inventory $125M $164M $232M $205M $200M
Prepaid Expenses $329M $103M $73M $68M $92M
Other Current Assets $42M $60M $73M $62M $90M
Total Current Assets $2B $2.2B $2.7B $2.9B $3.2B
 
Property Plant And Equipment $10B $12B $14.9B $16B $17.3B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $5.5B $6B $5.9B $6.9B
Other Intangibles $648M $615M $452M $670M $663M
Other Long-Term Assets $38M $42M $47M $43M $49M
Total Assets $17.9B $20.3B $24.2B $25.6B $28.2B
 
Accounts Payable $466M $816M $1.1B $905M $748M
Accrued Expenses $217M $221M $272M $325M $367M
Current Portion Of Long-Term Debt $704M $906M $161M $1.5B $1.2B
Current Portion Of Capital Lease Obligations $178M $202M $211M $249M $294M
Other Current Liabilities $77M $85M $137M $168M $223M
Total Current Liabilities $1.9B $2.6B $2.4B $3.6B $3.3B
 
Long-Term Debt $9B $8.8B $11.2B $10.1B $12.2B
Capital Leases -- -- -- -- --
Total Liabilities $13.3B $14.3B $17.1B $17.5B $19.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$146M -$171M -$264M -$228M -$405M
Common Equity $4.5B $6B $7.1B $8.1B $8.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.5B $6B $7.1B $8.1B $8.6B
 
Total Liabilities and Equity $17.9B $20.3B $24.2B $25.6B $28.2B
Cash and Short Terms $202M $144M $106M $363M $457M
Total Debt $9.7B $9.7B $11.4B $11.5B $13.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $202M $144M $106M $363M $457M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.7B $2B $2.2B $2.4B
Inventory $125M $164M $232M $205M $200M
Prepaid Expenses $329M $103M $73M $68M $92M
Other Current Assets $42M $60M $73M $62M $90M
Total Current Assets $2B $2.2B $2.7B $2.9B $3.2B
 
Property Plant And Equipment $10B $12B $14.9B $16B $17.3B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $5.5B $6B $5.9B $6.9B
Other Intangibles $648M $615M $452M $670M $663M
Other Long-Term Assets $38M $42M $47M $43M $49M
Total Assets $17.9B $20.3B $24.2B $25.6B $28.2B
 
Accounts Payable $466M $816M $1.1B $905M $748M
Accrued Expenses $217M $221M $272M $325M $367M
Current Portion Of Long-Term Debt $704M $906M $161M $1.5B $1.2B
Current Portion Of Capital Lease Obligations $178M $202M $211M $249M $294M
Other Current Liabilities $77M $85M $137M $168M $223M
Total Current Liabilities $1.9B $2.6B $2.4B $3.6B $3.3B
 
Long-Term Debt $9B $8.8B $11.2B $10.1B $12.2B
Capital Leases -- -- -- -- --
Total Liabilities $13.3B $14.3B $17.1B $17.5B $19.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$146M -$171M -$264M -$228M -$405M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.5B $6B $7.1B $8.1B $8.6B
 
Total Liabilities and Equity $17.9B $20.3B $24.2B $25.6B $28.2B
Cash and Short Terms $202M $144M $106M $363M $457M
Total Debt $9.7B $9.7B $11.4B $11.5B $13.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $890M $1.4B $2.1B $2.4B $2.6B
Depreciation & Amoritzation $2B $2B $2.2B $2.8B $2.9B
Stock-Based Compensation $70M $119M $127M $94M $112M
Change in Accounts Receivable $218M -$300M -$329M -$167M -$20M
Change in Inventories -$5M $9M -$25M $19M $15M
Cash From Operations $2.7B $3.7B $4.4B $4.7B $4.5B
 
Capital Expenditures $1.2B $3.2B $3.7B $4.1B $4.1B
Cash Acquisitions -$2M -$1.4B -$2.3B -$574M -$1.7B
Cash From Investing -$223M -$3.6B -$5B -$3B -$4.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$406M -$434M
Special Dividend Paid
Long-Term Debt Issued $9.3B $8.4B $9.9B $8.6B $11.6B
Long-Term Debt Repaid -$11.2B -$8.5B -$8.2B -$8.6B -$9.9B
Repurchase of Common Stock -$286M -$34M -$1.1B -$1.1B -$1.6B
Other Financing Activities -$23M -$8M -$24M -- -$17M
Cash From Financing -$2.3B -$140M $552M -$1.5B -$274M
 
Beginning Cash (CF) $52M $202M $144M $106M $363M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $142M -$62M -$31M $254M $124M
Ending Cash (CF) $202M $144M $106M $363M $457M
 
Levered Free Cash Flow $1.5B $491M $743M $634M $419M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $297M $481M $639M $679M $689M
Depreciation & Amoritzation $480M $532M $577M $697M $762M
Stock-Based Compensation $24M $30M $32M $22M $33M
Change in Accounts Receivable $16M -$76M -$68M $87M $31M
Change in Inventories -$17M $1M $8M -$3M $10M
Cash From Operations $370M $668M $1.3B $1.4B $1B
 
Capital Expenditures $228M $748M $1.1B $725M $683M
Cash Acquisitions -- -$1M -$2B -$168M -$313M
Cash From Investing $63M -$408M -$2.6B -$437M -$515M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$101M -$108M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B $1.3B $4.7B $1.9B $1.9B
Long-Term Debt Repaid -$2.4B -$1.8B -$3.2B -$2.4B -$1.9B
Repurchase of Common Stock -$5M -$1M -$10M -$264M -$403M
Other Financing Activities -- -- -$15M -- --
Cash From Financing -$412M -$435M $1.4B -$906M -$528M
 
Beginning Cash (CF) $174M $320M $76M $284M $479M
Foreign Exchange Rate Adjustment $7M -$1M -$1M $8M -$27M
Additions / Reductions $21M -$175M $31M $71M $5M
Ending Cash (CF) $202M $144M $106M $363M $457M
 
Levered Free Cash Flow $142M -$80M $199M $689M $365M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $890M $1.4B $2.1B $2.4B $2.6B
Depreciation & Amoritzation $2B $2B $2.2B $2.8B $2.9B
Stock-Based Compensation $70M $119M $127M $94M $112M
Change in Accounts Receivable $218M -$300M -$329M -$167M -$20M
Change in Inventories -$5M $9M -$25M $19M $15M
Cash From Operations $2.7B $3.7B $4.4B $4.7B $4.5B
 
Capital Expenditures $1.2B $3.2B $3.7B $4.1B $4.1B
Cash Acquisitions -$2M -$1.4B -$2.3B -$574M -$1.7B
Cash From Investing -$223M -$3.6B -$5B -$3B -$4.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$406M -$434M
Special Dividend Paid
Long-Term Debt Issued $9.3B $8.4B $9.9B $8.6B $11.6B
Long-Term Debt Repaid -$11.2B -$8.5B -$8.2B -$8.6B -$9.9B
Repurchase of Common Stock -$286M -$34M -$1.1B -$1.1B -$1.6B
Other Financing Activities -$23M -- -- -- -$17M
Cash From Financing -$2.3B -$140M $552M -$1.5B -$274M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $142M -$62M -$31M $254M $124M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.5B $491M $743M $634M $419M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1.4B $2.1B $2.4B $2.6B --
Depreciation & Amoritzation $2B $2.2B $2.8B $2.9B --
Stock-Based Compensation $119M $127M $94M $112M --
Change in Accounts Receivable -$300M -$329M -$167M -$20M --
Change in Inventories $9M -$25M $19M $15M --
Cash From Operations $3.7B $4.4B $4.7B $4.5B --
 
Capital Expenditures $3.2B $3.7B $4.1B $4.1B --
Cash Acquisitions -$1.4B -$2.3B -$574M -$1.7B --
Cash From Investing -$3.6B -$5B -$3B -$4.1B --
 
Dividends Paid (Ex Special Dividend) -- -- -$406M -$434M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $8.4B $9.9B $8.6B $11.6B --
Long-Term Debt Repaid -$8.5B -$8.2B -$8.6B -$9.9B --
Repurchase of Common Stock -$34M -$1.1B -$1.1B -$1.6B --
Other Financing Activities -$8M -$24M -- -$17M --
Cash From Financing -$140M $552M -$1.5B -$274M --
 
Beginning Cash (CF) $1.1B $389M $716M $1.7B --
Foreign Exchange Rate Adjustment $4M -$7M $3M -$30M --
Additions / Reductions -$62M -$31M $254M $124M --
Ending Cash (CF) $1.1B $351M $973M $1.8B --
 
Levered Free Cash Flow $491M $743M $634M $419M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
75
CORT alert for Apr 2

Corcept Therapeutics [CORT] is down 8.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock